Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

In rats, neurodevelopmental disorders induced by maternal hypoxia are associated with attenuated excitatory neurotransmission in the cingulate cortex.

British journal of pharmacology·2026
Same author

A comparative analysis of regulatory frameworks and their market impacts on health functional foods: perspectives from South Korea, Canada, the United States, and China.

Critical reviews in food science and nutrition·2026
Same author

Contrasting effects of PHD finger protein 24 (PHF24) on brain morphology of the spontaneous generalized tonic-clonic seizure model; Noda epileptic rat (NER) and Phf24-null rat.

Experimental animals·2026
Same author

CRISPR/Cas strategies to enhance CAR T-cell function and persistence via metabolic reprogramming.

Trends in biotechnology·2026
Same author

Ameliorative effects of Kir4.1 channel inhibitors on lipopolysaccharide-induced cognitive impairment via BDNF/TrkB signaling pathway.

Journal of pharmacological sciences·2025
Same author

Anti-HIV-1 HSPC-based gene therapy with safety kill switch to defend against and attack HIV-1 infection.

Molecular therapy. Methods & clinical development·2025

Related Experiment Video

Updated: Jun 5, 2026

Stem-cell Based Engineered Immunity Against HIV Infection in the Humanized Mouse Model
11:38

Stem-cell Based Engineered Immunity Against HIV Infection in the Humanized Mouse Model

Published on: July 2, 2016

Stem cell-based anti-HIV gene therapy.

Scott G Kitchen1, Saki Shimizu, Dong Sung An

  • 1The David Geffen School of Medicine, University of California, Los Angeles, CA, USA.

Virology
|January 21, 2011
PubMed
Summary
This summary is machine-generated.

Human stem cell gene therapy offers a promising new avenue for HIV treatment, aiming for a potential cure. This approach uses engineered stem cells to continuously generate HIV-resistant immune cells, offering a lasting solution.

More Related Videos

Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy
12:03

Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy

Published on: September 5, 2016

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant
08:52

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant

Published on: May 27, 2011

Related Experiment Videos

Last Updated: Jun 5, 2026

Stem-cell Based Engineered Immunity Against HIV Infection in the Humanized Mouse Model
11:38

Stem-cell Based Engineered Immunity Against HIV Infection in the Humanized Mouse Model

Published on: July 2, 2016

Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy
12:03

Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy

Published on: September 5, 2016

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant
08:52

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant

Published on: May 27, 2011

Area of Science:

  • Immunology
  • Gene Therapy
  • Hematopoietic Stem Cells

Background:

  • Human stem cell-based therapies are re-emerging as a key strategy for HIV treatment.
  • Unlike conventional antivirals, engineered stem cells can continuously produce protected immune cells.
  • This offers a potential for a single or minimal treatment to control and eradicate HIV.

Purpose of the Study:

  • To review current stem cell-based gene therapy approaches for HIV.
  • To discuss strategies for protecting cells from HIV infection.
  • To explore methods for targeting immune cells to combat HIV.

Main Methods:

  • Focus on genetically engineered hematopoietic stem cells.
  • Development of novel gene therapy technologies.
  • Review of ongoing clinical trials for stem cell-based HIV interventions.

Main Results:

  • Stem cell gene therapy holds potential for long-term HIV control.
  • Engineered cells can provide a continuous source of protected immune cells.
  • Two primary strategies are being developed: cellular protection and immune cell targeting.

Conclusions:

  • Stem cell-based gene therapy represents a significant advancement in HIV treatment research.
  • The potential for a functional cure through continuous immune cell production is a major breakthrough.
  • Further development and clinical trials are crucial for realizing the full potential of these therapies.